Biotech

All Articles

' Scientific intuitiveness' led FDA specialists to support Zevra's unusual illness med

.Zevra Therapies' uncommon disease drug appears to become on the pathway to confirmation this autumn...

Pfizer takes $230M hit after axing stopped working DMD gene treatment

.Pfizer's stage 3 Duchenne muscle dystrophy (DMD) genetics treatment failing has actually blown a $2...

AC Immune observes 'site' prospective in Alzheimer's medicine data

.After greater than twenty years of focus on neurodegenerative health conditions, Swiss biotech a/c ...

GSK drops ph. 2 HPV injection over lack of best-in-class possible

.GSK has actually scrapped a stage 2 human papillomavirus (HPV) injection coming from its pipeline a...

OS Therapies refiles $6M IPO to cash HER2 medication, preclinical ADCs

.OS Therapies will definitely specify on the NYSE American inventory exchange today by means of a $6...

ALX's waning CD47 response rate delivers sell spiraling down

.ALX Oncology's period 2 gastric cancer cells reaction fee has actually damaged. After viewing its o...

Ionis centers eye disease coming from intendeds of Roche-partnered prospect after information let down

.Another of Ionis Pharmaceuticals' key midphase readouts has actually fallen short of assumptions, u...

Biogen's chief executive officer mentioned no unsafe handle 2023. He's ready to be daring

.While Biogen's pharma peers are actually hunting for late-stage assets along with little risk, CEO ...

Instil refills pipeline in $2B biobucks handle ImmunOnco

.Instil Biography has actually been actually a biotech in search of a pipe after it junked its lead ...

Biogen bows out Denali Alzheimer's collab

.Biogen has actually restored civil liberties to a very early Alzheimer's illness plan to Denali The...